Program Overview

Harvard Medical School’s Master of Medical Science in Clinical Investigation (MMSCI) degree provides world-class training in the methods and conduct of clinical discovery for future leaders in patient-oriented and translational research. This two-year program, which requires students to reside in Boston for its duration, combines innovative forms of pedagogy from leading Harvard faculty with an individual mentored research experience. Each student is provided the opportunity to perform cutting-edge research in a Harvard-based laboratory under the direct supervision of a Harvard mentor.

The MMSCI program is designed for postgraduate clinician-scientists working in clinical or translational research at the fellowship and junior faculty level (or equivalent). Candidates holding an MD, MBBS, MBBCh, PhD or comparable academic degree are eligible to apply.

The program format features three intensive workshops across a two-year span. Between each workshop, students will continue to acquire core knowledge and skills by way of longitudinal lectures and a course in Contemporary Topics in Clinical and Translational Investigation. In addition to the traditional learning of biostatistics, epidemiology and translational methods, our goal is to promote the development of critical thinking skills, writing and presentation skills, and leadership experience

Program Key Features:

  • A two-year intensive, mentored research experience at a Harvard-affiliated laboratory in Boston
  • Leading clinical and translational research faculty from Harvard Medical School, Harvard T.H. Chan School of Public Health and laboratories from Harvard-affiliated organizations
  • Fully integrated curriculum designed specifically for MMSCI students
  • Contemporary pedagogical approaches such as “flipped classroom” methods, team-based learning and development of critical thinking skills
  • Specialized tracks and pathways for individualized learning

Specialized Tracks and Pathways for Individualized Learning

To complement individual learning and development, the MMSCI program provides students the choice of a Clinical Investigation (CI) or a Translational Investigation (TI) track, and places a core emphasis on practical skills and team-based approaches in each track’s training. Additionally, the CI track offers a choice of comparative research pathway or a clinical trials pathway for individualized learning.

This program begins on July 6, 2020.
    Program Overview with Ajay Singh
    Program Overview with Ajay Singh
    • Want to Learn More?

      Get access to the latest information and stay up-to-date on program details by completing the form below.